Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal

Journal of Cellular Physiology

Volumn 226, Issue 7, 2011, Pages 1813-1819

  Jalili, Reza B ^a,b   Moeen Rezakhanlou, Alireza ^a   Hosseini Tabatabaei, Azadeh ^a   Ao, Ziliang ^a   Warnock, Garth L ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBROBLAST POPULATED COLLAGEN MATRIX; FIBRONECTIN; GROWTH FACTOR; INSULIN; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COMPOSITE GRAFT; CONTROLLED STUDY; FIBROBLAST; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TISSUE SURVIVAL; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; DIABETES MELLITUS, EXPERIMENTAL; FIBROBLASTS; FIBRONECTINS; GRAFT SURVIVAL; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TISSUE SCAFFOLDS;

MURINAE;

EID: 79954630540     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22515     Document Type: Article

References (42)

1. Abraham DJ, Eckes B, Rajkumar V, Krieg T. 2007. New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma. Curr Rheumatol Rep 9:136-143.
2. Barbu AR, Akusjarvi G, Welsh N. 2005. Adenoviral-mediated transduction of human pancreatic islets: Importance of adenoviral genome for cell viability and association with a deficient antiviral response. Endocrinology 146:2406-2414.
3. Bharat A, Benshoff N, Olack B, Ramachandran S, Desai NM, Mohanakumar T. 2005. Novel in vivo murine model to study islet potency: Engraftment and function. Transplantation 79:1627-1630.
4. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. 2002. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66-72.
5. Blomeier H, Zhang X, Rives C, Brissova M, Hughes E, Baker M, Powers AC, Kaufman DB, Shea LD, Lowe WL, Jr. 2006. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation 82:452-459.
6. Bosco D, Meda P, Halban PA, Rouiller DG. 2000. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: Role of alpha6beta1 integrin. Diabetes 49:233-243.
7. Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, Kantz J, Chen Z, Carr C, Jerome WG, Chen J, Baldwin HS, Nicholson W, Bader DM, Jetton T, Gannon M, Powers AC. 2006. Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974-2985.
8. Carlson MA, Longaker MT. 2004. The fibroblast-populated collagen matrix as a model of wound healing: A review of the evidence. Wound Repair Regen 12:134-147.
9. Chao SH, Peshwa MV, Sutherland DE, Hu WS. 1992. Entrapment of cultured pancreas islets in three-dimensional collagen matrices. Cell Transplant 1:51-60.
10. Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. 1995. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 59:817-820.
11. Emamaullee JA, Stanton L, Schur C, Shapiro AM. 2007. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes 56:1289-1298.
12. Emamaullee JA, Shapiro AM. 2006. Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes 55:1907-1914.
13. Fringer J, Grinnell F. 2001. Fibroblast quiescence in floating or released collagen matrices. Contribution of the erk signaling pathway and actin cytoskeletal organization. J Biol Chem 276:31047-31052.
14. Garcia-Ocana A, Takane KK, Reddy VT, Lopez-Talavera JC, Vasavada RC, Stewart AF. 2003. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278:343-351.
15. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Jr., Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. 1999. The transcriptional program in the response of human fibroblasts to serum. Science 283:83-87.
16. Jalili RB, Forouzandeh F, Moeenrezakhanlou A, Rayat GR, Rajotte RV, Uludag H, Ghahary A. 2009. Mouse pancreatic islets are resistant to indoleamine 2, 3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function. Am J Pathol 174:196-205.
17. Jalili RB, Rayat GR, Rajotte RV, Ghahary A. 2007. Suppression of islet allogeneic immune response by indoleamine 2, 3 dioxygenase-expressing fibroblasts. J Cell Physiol 213:137-143.
18. Kaido T, Yebra M, Cirulli V, Montgomery AM. 2004. Regulation of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1beta1. J Biol Chem 279:53762-53769.
19. Kaido T, Yebra M, Cirulli V, Rhodes C, Diaferia G, Montgomery AM. 2006. Impact of defined matrix interactions on insulin production by cultured human {beta}-cells: Effect on insulin content, secretion, and gene transcription. Diabetes 55:2723-2729.
20. Kin T, O'Neil JJ, Pawlick R, Korbutt GS, Shapiro AM, Lakey JR. 2008. The use of an approved biodegradable polymer scaffold as a solid support system for improvement of islet engraftment. Artif Organs 32:990-993.
21. Lakey JR, Woods EJ, Zieger MA, Avila JG, Geary WA, Voytik-Harbin SL, Critser JK. 2001. Improved islet survival and in vitro function using solubilized small intestinal submucosa. Cell Tissue Bank 2:217-224.
22. Li M, Moeen Rezakhanlou A, Chavez-Munoz C, Lai A, Ghahary A. 2009. Keratinocyte-releasable factors increased the expression of MMP1 and MMP3 in co-cultured fibroblasts under both 2D and 3D culture conditions. Mol Cell Biochem 332:1-8.
23. Liu H, Chen B, Lilly B. 2008. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis 11:223-234.
24. Miki A, Narushima M, Okitsu T, Takeno Y, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, Tanaka K, Noguchi H, Matsumoto S, Kohara M, Lakey JR, Kobayashi E, Tanaka N, Kobayashi N. 2006. Maintenance of mouse, rat, and pig pancreatic islet functions by coculture with human islet-derived fibroblasts. Cell Transplant 15:325-334.
25. Nagata N, Gu Y, Hori H, Balamurugan AN, Touma M, Kawakami Y, Wang W, Baba TT, Satake A, Nozawa M, Tabata Y, Inoue K. 2001. Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix. Cell Transplant 10:447-451.
26. Perfetti R, Henderson TE, Wang Y, Montrose-Rafizadeh C, Egan JM. 1996. Insulin release and insulin mRNA levels in rat islets of Langerhans cultured on extracellular matrix. Pancreas 13:47-54.
27. Pileggi A, Ricordi C, Alessiani M, Inverardi L. 2001. Factors influencing Islet of Langerhans graft function and monitoring. Clin Chim Acta 310:3-16.
28. Pinkse GG, Bouwman WP, Jiawan-Lalai R, Terpstra OT, Bruijn JA, de Heer E. 2006. Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. Diabetes 55:312-317.
29. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC. 1994. DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733-738.
30. Rabinovitch A, Russell T, Mintz DH. 1979. Factors from fibroblasts promote pancreatic islet B cell survival in tissue culture. Diabetes 28:1108-1113.
31. Rosenberg L, Wang R, Paraskevas S, Maysinger D. 1999. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 126:393-398.
32. Rosenfeldt H, Grinnell F. 2000. Fibroblast quiescence and the disruption of ERK signaling in mechanically unloaded collagen matrices. J Biol Chem 275:3088-3092.
33. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. 2005. Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069.
34. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238.
35. Stendahl JC, Kaufman DB, Stupp SI. 2009. Extracellular matrix in pancreatic islets: Relevance to scaffold design and transplantation. Cell Transplant 18:1-12.
36. Su D, Zhang N, He J, Qu S, Slusher S, Bottino R, Bertera S, Bromberg J, Dong HH. 2007. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 56:2274-2283.
37. Thomas FT, Contreras JL, Bilbao G, Ricordi C, Curiel D, Thomas JM. 1999. Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. Surgery 126:299-304.
38. Tian XH, Xue WJ, Ding XM, Pang XL, Teng Y, Tian PX, Feng XS. 2005. Small intestinal submucosa improves islet survival and function during in vitro culture. World J Gastroenterol 11:7378-7383.
39. Van JH, Van Suylichem PT, Wolters GH, Van Schilfgaarde R. 1994. Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res 277:115-121.
40. Wang RN, Rosenberg L. 1999. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol 163:181-190.
41. Weber M, Deng S, Kucher T, Shaked A, Ketchum RJ, Brayman KL. 1997. Adenoviral transfection of isolated pancreatic islets: A study of programmed cell death (apoptosis) and islet function. J Surg Res 69:23-32.
42. Yang Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler JL. 2005. Inflammatory blockade improves human pancreatic islet function and viability. Am J Transplant 5:475-483.